Astrocyte Heterogeneity and Metabolic Reprogramming: Mechanisms Governing Retinal Ganglion Cell Damage in Glaucoma.

Area of Science:

• Neuroscience
• Ophthalmology
• Cell Biology

Background:

• Glaucoma causes irreversible vision loss through retinal ganglion cell (RGC) degeneration.
• Astrocytes, once considered supportive cells, are now recognized as critical players in glaucoma pathogenesis.
• Astrocyte heterogeneity and metabolic reprogramming significantly influence RGC survival in glaucoma.

Purpose of the Study:

• To review current knowledge on astrocyte diversity and metabolic alterations in glaucoma-induced RGC injury.
• To synthesize molecular mechanisms, particularly from proteomic studies, underlying astrocyte dysfunction.
• To highlight key pathways like fatty acid metabolism and neuroinflammation involved in RGC degeneration.

Main Methods:

• Comprehensive literature review of studies on astrocytes in glaucoma.
• Analysis of proteomic data to identify molecular mechanisms.
• Synthesis of information on metabolic reprogramming and signaling pathways.

Main Results:

• Astrocytes exhibit significant heterogeneity, with distinct subtypes contributing differently to RGC injury.
• Pathological metabolic reprogramming in astrocytes, including altered fatty acid metabolism, impacts RGC survival.
• Neuroinflammation and specific signaling pathways involving astrocytes exacerbate RGC neurodegeneration.

Conclusions:

• Understanding astrocyte heterogeneity and metabolic reprogramming is crucial for developing targeted glaucoma therapies.
• Identifying specific astrocyte subtypes and metabolic/inflammatory targets holds promise for future treatments.
• Novel theoretical frameworks are proposed to guide therapeutic strategies aimed at protecting RGCs by modulating astrocyte function.